Evaluation of the prevalence and seasonality of human parainfluenza virus over five year period in pediatric patients HPIV in pediatric patients

Main Article Content

Meryem Colak
Selin Yigit
Anil Tapisiz
Hager Muftah
Kenan Yuce
Hasan Tezer
Gulendam Bozdayi


Objective: Human Parainfluenza viruses (HPIVs) cause respiratory tract infections, and the second most common cause of acute respiratory illness-related hospitalizations after the respiratory syncytial virus in children <5 years of age. The aim of the study; determination of HPIVs positivity and common types in pediatric patients with respiratory tract infection; investigation the distribution of HPIV positivity by age groups, months and seasons, respectively.

Material and Method: HPIV results of 1613 pediatric patients who were sent to the molecular virology laboratory from various pediatric clinics of Gazi Hospital between March 2016 and February 2021 (five years period) were investigated. Nucleic acid isolation was performed on the EZ1 Advanced (Qiagen, Germany) device using the EZ1 Virus Mini Kit by the manufacturer's protocol.

Results: HPIV positivity was detected as 4.1% in clinical samples and, the most common HPIV type was found to be HPIV-3 (55%). The distribution of other HPIV types were; HPIV-2, HPIV-4 and HPIV-1 with 26%, 23% and 14%, respectively. HPIV-3 is the most common type in 2016, 2017, 2018 and 2019; however, HPIV-1 is the most common type in 2020. HPIVs co-infection was detected with other respiratory tract viruses in 51% of samples. The highest HPIV co-infection was detected in Rhinovirus. The highest HPIV positivity rate (45%) were determined in the 0-2 age group compared to other age groups (p<0.05). The highest positivity rate was in October in the autumn season (p<0.05), the lowest was in January and February in winter. The highest rate (8.1%) of HPIV positivity was found in 2016 and the lowest rate (0.7%) was in 2020.

Conclusions: Since it is not possible to diagnose viral etiology of respiratory tract infections based on clinical findings, viral respiratory tract panel and Multiplex real-time PCR test are a fast and useful method in early diagnosis, treatment decision and prevention of unnecessary antibiotic use. HPIVs positivity is seen at higher rates in children aged 0-2 and in autumn months with seasonal differences.


Download data is not yet available.

Article Details

How to Cite
Colak, M., Yigit, S., Tapisiz, A., Muftah, H., Yuce, K., Tezer, H., & Bozdayi, G. (2021). Evaluation of the prevalence and seasonality of human parainfluenza virus over five year period in pediatric patients. Medical Science and Discovery, 8(4), 260-265. https://doi.org/10.36472/msd.v8i4.530
Research Article


1. Rafeek RAM, Divarathna MVM, Noordeen F. A review on disease burden and epidemiology of childhood parainfluenza virus infections in Asian countries. Rev Med Virol. 2020;e2164.

2. Zhao H, Harris RJ, Ellis J, Donati M, Pebody RG. Epidemiology of parainfluenza infection in England and Wales, 1998-2013: any evidence of change? Epidemiol Infect. 2017;145(6):1210-20.

3. Rima B, Balkema-Buschmann A, Dundon WG, Duprex P, Easton A, et al. ICTV virus taxonomy profile: Paramyxoviridae. J Gen Virol. 2019;100(12): 1593.

4. Pawełczyk M, Kowalski ML. The role of human parainfluenza virus infections in the immunopathology of the respiratory tract. Curr Allergy Asthma Rep. 2017;17(3):16.

5. Branche AR, Falsey AR. Parainfluenza Virus Infection. Semin Respir Crit Care Med. 2016;37(4):538-54.

6. Deng J, Ma Z, Huang W, Li C, Wang H, Zheng Y, et al. Respiratory virus multiplex RT-PCR assay sensitivities and influence factors in hospitalized children with lower respiratory tract infections. Virol Sin. 2013;28:97-102.

7. Van Doorn HR, Yu H. Viral respiratory infections. In: Ryan ET, Hill DR, Solomon T, Aronson NE, Endy TP (eds). Hunter's Tropical Medicine and Emerging Infectious Diseases.10th ed. New York: Philadelphia, 2020;284-8.

8. Aykac K, Karadag-Oncel E, Bayhan C, Tanir Basaranoglu S, Akin MS, Ozsurekci Y, et al. Prevalence and seasonal distribution of viral etiology of respiratory tract infections in inpatients and outpatients of the pediatric population: 10 year follow-up. Turk J Ped. 2018;60:642-52.

9. DeGroote NP, Haynes AK, Taylor C, Killerby ME, Dahl RM, Mustaquim D et al. Human parainfluenza virus circulation, United States, 2011–2019. J Clin Virol. 2020;124,104261.

10. Görkem A, Uğur AR, Feyzioğlu B, Özdemir M, Baykan M. Investigation of Parainfluenza Virus Caused Lower Respiratory Tract Infections in Pediatric Patients. Selcuk Med J. 2020;36(2):87-90.

11. Appak O, Duman M, Belet N, Sayiner AA. Viral respiratory infections diagnosed by multiplex polymerase chain reaction in pediatric patients. J Med Virol. 2019; 91(5):731-7.

12. Gu YE, Park JY, Lee MK, Lim IS. Characteristics of human parainfluenza virus type 4 infection in hospitalized children in Korea. Pediatr Int. 2020;62(1):52-8.

13. Zhong P, Zhang H, Chen X, Lv F. Clinical characteristics of the lower respiratory tract infection caused by a single infection or coinfection of the human parainfluenza virus in children. J Med Virol. 2019;91(9):1625-32.

14. Bayrakdar F, Altaş AB; Korukluoğlu G. Seasonal Distribution of the Respiratory Tract Viruses in Turkey Between 2009-2012. Turk Mikrobiyol Cem Derg. 2013;43:56-66.

15. Li Y, Reeves RM, Wang X, Bassat Q, Brooks WA, Cohen C, Zar HJ. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health. 2019;7(8):e1031-e1045.

16. Liu WK, Chen DH, Tan WP, Qiu SY, Xu D, Zhang L, et al. Paramyxoviruses respiratory syncytial virus, parainfluenza virus, and human metapneumovirus infection in pediatric hospitalized patients and climate correlation in a subtropical region of southern China: a 7-year survey. Eur J Clin Microbiol Infect Dis. 2019;38(12):2355-64.

17. Thomazelli LM, Oliveira DB, Durigon GS, Whitaker B, Kamili S, Berezin EN et al. Human parainfluenzavirus surveillance in pediatric patients with lower respiratory tract infections: a special view of parainfluenza type 4. J Pediatr. 2018;94:554-8.

18. Weeliver RC. Parainfluenza viruses. In: James DC, Gail LH, Sheldon LK et al, eds. Feigin and Cherry’s Textbook of Pediatric Infectious Diseases. Elsevier, Philadelphia, 2019;1745–53.

19. Frost HM, Robinson CC, Dominguez SR. Epidemiology and clinical presentation of parainfluenza type 4 in children: a 3 year comparative study to parainfluenza types 1–3. J Infect Dis. 2014;209:695-702.

20. Abedi GR, Prill MM, Langley GE, Wikswo ME, Weinberg GA, Curns AT, et al. Estimates of parainfluenza virus-associated hospitalizations and cost among children aged less than 5 years in the United States, 1998–2010. Pediatr Infect Dis J. 2016;5:7-13.

21. European Centre for Disease Prevention and Control (ECDC). Communicable Diseases Threats Report Week 10, 7-13 March 2021. Stockholm: ECDC; 2021.

22. Sullivan SG, Carlson S, Cheng AC, Chilver MB, Dwyer DE, Irwin M, et al. Where has all the influenza gone? Eurosurveillance. 2020;25(47):2001847.